Skip to nav Skip to content

2681 article(s) found

When Jenny De Furio was diagnosed with stage 3C breast cancer in 2024, she decided to go on a clinical trial rather than start with the standard of care treatment. She embraced the chance to be part of a more personalized experimental approach.

Thinking Outside the Box With Adaptive Breast Cancer Clinical Trial

Adaptive clinical trial gives earlier stage breast cancer patient chance to pioneer next generation of treatments 

Photo of Dr. Fred Locke on stage at the podium at Cell Coast 2026

Cell Therapy Changed Cancer Care. Now Researchers Want to Make It Work Better

Moffitt brought together experts from across the country to explore ways to make cell therapies more durable and effective for more patients

Surgery has long been the standard of care for women with ductal carcinoma in situ, or noninvasive stage 0 breast cancer.

Is Surgery the Only Option for Women With Stage 0 Breast Cancer?

RECAST clinical trial explores estrogen blockers as a nonsurgical approach

Four women wearing pink shirts with pink breast cancer awareness ribbons

5 Questions About Metastatic Breast Cancer

Moffitt Cancer Center expert explains what you need to know

Can You Bust These Flu Myths?

From vaccine safety to flu complications, Moffitt infectious disease expert clears up common misconceptions about the flu

Metastatic Breast Cancer Patient Continues To Watch Family Grow Thanks to Clinical Trial

Tamara Holt was 42 with two young sons when she was diagnosed with triple-negative breast cancer

Moffitt Trial Tests Immunotherapy Without Chemotherapy for Early Stage Breast Cancer

Florida mother had a complete response to dendritic cell vaccines prior to surgery

‘Find a Purpose’: Patient Shares Lessons From Cancer Journey

One year since his cancer diagnosis, William Sheer encourages others to maintain their positivity despite the challenges

Dr. Jose Beltran crossing the finish line at an Ironman race

From Finish Lines to Infusion Chairs: One Athlete's Journey Through Rare Cancer

After a mantle cell lymphoma diagnosis, Jose Beltran sought a second opinion and found a new path through an immunotherapy clinical trial